Tremlett Helen, Devonshire Virginia
Department of Medicine (Neurology), Rm. S159, 2211 Wesbrook Mall, University of British Columbia, Vancouver, BC V6T 2B5, Canada.
Neurology. 2006 Sep 26;67(6):954-9. doi: 10.1212/01.wnl.0000237475.01655.9d.
To describe the characteristics of late-onset multiple sclerosis (MS) (LOMS, 50+ years) vs adult-onset MS (AOMS, 16 to <50 years) and examine prognosis and associated risk factors.
Patients with definite MS, onset prior to July 1988, registered with a BCMS clinic before July 1998, with at least one Expanded Disability Status Scale (EDSS) score, were selected from the longitudinal population-based British Columbian (BC) MS database. Clinical and demographic characteristics were compared between LO and AOMS. Progression was measured as time to reach sustained EDSS 6 and potential risk factors examined were sex, disease course (primary progressive [PP] vs relapsing [R]), and onset symptoms.
Of those eligible (n = 2,837), LOMS comprised 132 (4.7%), with PPMS predominating (54.5% vs 10.6% in AOMS, p < 0.0005). Motor onset symptoms were more prevalent in LOMS and sensory and optic neuropathy more prevalent in AOMS (p < 0.0005). AOMS averaged 27.7 years (95% CI: 26.3 to 29.1) to EDSS 6 from onset vs 16.9 years (95% CI: 9.0 to 24.8) in LOMS, p < 0.0005. However, AOMS was associated with a younger age at EDSS 6 (58.4 years [95% CI: 57.1 to 59.6] vs 71.2 years [95% CI: 65.2 to 77.3] in LOMS, p < 0.0005). There were no differences in progression between AO or LO for those with PPMS (p = 0.373) or R-MS (p = 0.438), although considerable variation was observed.
Late-onset multiple sclerosis (LOMS) is not necessarily associated with a worse outcome: first, progression in the primary progressive or relapsing patients differed little between late-onset vs adult-onset; secondly, those with LOMS were older when reaching Expanded Disability Status Scale 6. The disease course has a far greater implication for disease prognosis than the presence of LOMS.
描述晚发型多发性硬化症(LOMS,年龄≥50岁)与成人发病型多发性硬化症(AOMS,年龄16至<50岁)的特征,并研究其预后及相关危险因素。
从基于人群的纵向不列颠哥伦比亚省(BC)多发性硬化症数据库中,选取1988年7月前发病、1998年7月前在BCMS诊所登记且至少有一次扩展残疾状态量表(EDSS)评分的确诊多发性硬化症患者。比较LOMS和AOMS的临床及人口统计学特征。以达到持续EDSS 6的时间衡量疾病进展,研究的潜在危险因素包括性别、病程(原发进展型[PP]与复发型[R])及起病症状。
在符合条件的2837例患者中,LOMS有132例(4.7%),以原发进展型多发性硬化症(PPMS)为主(54.5%,而AOMS中为10.6%,p<0.0005)。运动起病症状在LOMS中更常见,感觉和视神经病变在AOMS中更常见(p<0.0005)。AOMS从发病到EDSS 6平均需要27.7年(95%CI:26.3至29.1),而LOMS为16.9年(95%CI:9.0至24.8),p<0.0005。然而,达到EDSS 6时AOMS患者年龄较轻(58.4岁[95%CI:57.1至59.6],而LOMS为71.2岁[95%CI:65.2至77.3],p<0.0005)。对于PPMS患者(p = 0.373)或复发缓解型多发性硬化症(R-MS)患者(p = 0.438),成人发病型与晚发型在疾病进展方面无差异,尽管存在相当大的变异性。
晚发型多发性硬化症(LOMS)不一定预后更差:其一,原发进展型或复发型患者中,晚发型与成人发病型在疾病进展方面差异不大;其二,达到扩展残疾状态量表6时,LOMS患者年龄更大。病程对疾病预后的影响远大于晚发型的存在。